CRP and obesity due to melanocortin 4 receptor deficiency: When looking at different markers of disease activity from week 8 to week 48, higher tender joint counts, CRP and assessment scores of disease activity and pain were observed in participants with obesity compared with the rest of the cohort (figure 3A).